Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 319

1.

Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.

Finn WG, Singleton TP, Schnitzer B, Ross CW, Stoolman LM.

Hum Pathol. 2001 Jan;32(1):66-73.

PMID:
11172297
[PubMed - indexed for MEDLINE]
2.

Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.

Lúcio PJ, Faria MT, Pinto AM, da Silva MR, Correia Júnior ME, da Costa RJ, Parreira AB.

Haematologica. 1998 Feb;83(2):104-11.

PMID:
9549920
[PubMed - indexed for MEDLINE]
Free Article
3.

Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features.

Terol MJ, López-Guillermo A, Bosch F, Villamor N, Cid MC, Campo E, Montserrat E.

J Clin Oncol. 1999 Jun;17(6):1869-75.

PMID:
10561227
[PubMed - indexed for MEDLINE]
4.

Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: malignant cell phenotypes define distinct disease subsets.

De Rossi G, Zarcone D, Mauro F, Cerruti G, Tenca C, Puccetti A, Mandelli F, Grossi CE.

Blood. 1993 May 15;81(10):2679-87.

PMID:
7683926
[PubMed - indexed for MEDLINE]
Free Article
5.

Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.

Csanaky G, Matutes E, Vass JA, Morilla R, Catovsky D.

Leukemia. 1997 Mar;11(3):408-15.

PMID:
9067581
[PubMed - indexed for MEDLINE]
6.

Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.

Sánchez ML, Almeida J, Vidriales B, López-Berges MC, García-Marcos MA, Moro MJ, Corrales A, Calmuntia MJ, San Miguel JF, Orfao A.

Leukemia. 2002 Aug;16(8):1460-9.

PMID:
12145686
[PubMed - indexed for MEDLINE]
Free Article
7.

CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.

Huang JC, Finn WG, Goolsby CL, Variakojis D, Peterson LC.

Am J Clin Pathol. 1999 Jan;111(1):123-30.

PMID:
9894463
[PubMed - indexed for MEDLINE]
8.

Adhesion molecule profiles of B-cell non-Hodgkin's lymphomas in the leukemic phase.

Matos DM, Rizzatti EG, Garcia AB, Gallo DA, Falcão RP.

Braz J Med Biol Res. 2006 Oct;39(10):1349-55.

PMID:
17053842
[PubMed - indexed for MEDLINE]
Free Article
9.

[Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].

Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.

Ai Zheng. 2007 Apr;26(4):418-22. Chinese.

PMID:
17430665
[PubMed - indexed for MEDLINE]
10.

CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?

Sheikh SS, Kallakury BV, Al-Kuraya KA, Meck J, Hartmann DP, Bagg A.

Am J Hematol. 2002 Dec;71(4):306-10.

PMID:
12447961
[PubMed - indexed for MEDLINE]
11.

Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.

de Leon ED, Alkan S, Huang JC, Hsi ED.

Mod Pathol. 1998 Nov;11(11):1046-51.

PMID:
9831200
[PubMed - indexed for MEDLINE]
12.
13.

A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.

Zucchetto A, Bomben R, Dal Bo M, Sonego P, Nanni P, Rupolo M, Bulian P, Dal Maso L, Del Poeta G, Del Principe MI, Degan M, Gattei V.

J Cell Physiol. 2006 May;207(2):354-63.

PMID:
16331666
[PubMed - indexed for MEDLINE]
14.

Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.

Yegappan S, Coupland R, Arber DA, Wang N, Miocinovic R, Tubbs RR, Hsi ED.

Mod Pathol. 2001 Nov;14(11):1147-56.

PMID:
11706077
[PubMed - indexed for MEDLINE]
Free Article
15.

Surface phenotype and Ig heavy-chain gene usage in chronic B-cell leukemias: expression of myelomonocytic surface markers in CD5- chronic B-cell leukemia.

Ikematsu W, Ikematsu H, Okamura S, Otsuka T, Harada M, Niho Y.

Blood. 1994 May 1;83(9):2602-10.

PMID:
7513207
[PubMed - indexed for MEDLINE]
Free Article
16.

CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.

Hanson CA, Gribbin TE, Schnitzer B, Schlegelmilch JA, Mitchell BS, Stoolman LM.

Blood. 1990 Dec 1;76(11):2360-7.

PMID:
1701669
[PubMed - indexed for MEDLINE]
Free Article
17.

Adhesion molecules in B-chronic lymphoproliferative disorders.

Angelopoulou MK, Kontopidou FN, Pangalis GA.

Semin Hematol. 1999 Apr;36(2):178-97. Review.

PMID:
10319387
[PubMed - indexed for MEDLINE]
18.

Differential expression of very late activation antigen-3 (VLA-3)/VLA-4 in B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia.

Baldini L, Cro L, Calori R, Nobili L, Silvestris I, Maiolo AT.

Blood. 1992 May 15;79(10):2688-93.

PMID:
1586717
[PubMed - indexed for MEDLINE]
Free Article
19.

Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.

Cavalcanti Júnior GB, Sales VS, Cavalcanti e Silva DG, Lopes MC, Paiva Ade S, da Fonseca HE, do Nascimento Júniors FF, Fernandes MZ.

Acta Cir Bras. 2005;20 Suppl 1:101-7.

PMID:
16186976
[PubMed - indexed for MEDLINE]
Free Article
20.

Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. A study of 242 cases.

Batata A, Shen B.

Cancer. 1992 Nov 15;70(10):2436-43.

PMID:
1384948
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk